open access

Vol 71, No 2 (2020)
Clinical Vignette
Published online: 2020-04-15
Submitted: 2019-12-02
Accepted: 2019-12-03
Get Citation

Difficulties in the diagnosis and treatment of malignant paraganglioma of the urinary bladder

Ewelina Rzepka, Aleksandra Gilis-Januszewska, Marta Opalińska, Anna Sowa-Staszczak, Alicja Hubalewska-Dydejczyk
DOI: 10.5603/EP.a2019.0068
·
Pubmed: 32293698
·
Endokrynologia Polska 2020;71(2):196-197.

open access

Vol 71, No 2 (2020)
Clinical Vignette
Published online: 2020-04-15
Submitted: 2019-12-02
Accepted: 2019-12-03

Abstract

Not required for Clinical Vignette.

Abstract

Not required for Clinical Vignette.

Get Citation

Keywords

paraganglioma; bladder; imaging; 68Ga-DOTATATE PET/CT; PRRT

About this article
Title

Difficulties in the diagnosis and treatment of malignant paraganglioma of the urinary bladder

Journal

Endokrynologia Polska

Issue

Vol 71, No 2 (2020)

Pages

196-197

Published online

2020-04-15

DOI

10.5603/EP.a2019.0068

Pubmed

32293698

Bibliographic record

Endokrynologia Polska 2020;71(2):196-197.

Keywords

paraganglioma
bladder
imaging
68Ga-DOTATATE PET/CT
PRRT

Authors

Ewelina Rzepka
Aleksandra Gilis-Januszewska
Marta Opalińska
Anna Sowa-Staszczak
Alicja Hubalewska-Dydejczyk

References (5)
  1. Zhai H, Ma X, Nie W, et al. Paraganglioma of the Urinary Bladder: A Series of 22 Cases in a Single Center. Clin Genitourin Cancer. 2017; 15(5): e765–e771.
  2. Asa SL, Ezzat S, Mete O. The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations. J Clin Med. 2018; 7(9).
  3. Janssen I, Chen CC, Millo CM, et al. PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2016; 43(10): 1784–1791.
  4. Satapathy S, Mittal BR, Bhansali A. 'Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: A systematic review and meta-analysis'. Clin Endocrinol (Oxf). 2019; 91(6): 718–727.
  5. Botling J, Lamarca A, Bajic D, et al. High-grade progression confers poor survival in pancreatic neuroendocrine tumors. Neuroendocrinology. 2019 [Epub ahead of print].

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl